March 2024 Newsletter
API Stories Innovation Unleashed: Highlights from the Life Sciences Investment Summit Finale Last week, we witnessed game-changing pitches from the Top 6 companies of Startup…
News Release: Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
Calgary, Canada – TheNewswire – March 4, 2024 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Corporation”) and Applied Pharmaceutical Innovation (API), a leading industry-funded not-for-profit organization…
February 2024 Newsletter
API Stories A night of innovation, inspiration, and collaboration Last week, we were inspired to witness 20 life sciences companies pitch for Startup TNT’s Life…
January 2024 Newsletter
API Stories Happy New Year from API! As we embrace the new year, we would like to start off by expressing our gratitude for your…
December 2023 Newsletter
API Stories A successful year for life sciences It has been a phenomenal year for Life Sciences in Alberta! From accelerating the growth of startups…
Fortify, attract, diversify: Unlocking the full potential of the Life Sciences in Alberta
As we begin to reflect on the close of a successful year, it’s clear that Life Sciences is a flourishing sector poised for continued growth…
November 2023 Newsletter
API Stories ASTech Awards 2023 Alberta-Wide Community Champion We are honoured to share that Andrew MacIsaac, API’s CEO, was recognized as this year’s Alberta-Wide Community…
Media Release: Applied Pharmaceutical Innovation Kicks Off Inaugural Life Sciences Week By Welcoming Nobel Laureate Sir Michael Houghton As Chief Scientific Officer
September 25, 2023 (Edmonton, Alberta) – Applied Pharmaceutical Innovation (API), an Edmonton-based not-for-profit, is rallying Alberta’s life sciences sector through a new province-wide celebration. Life Sciences…
Edmonton City Council has approved the lease needed for the Canadian Critical Drug Initiative manufacturing facility to be built in the Edmonton Research Park
August 30th, 2023, Edmonton, AB – Today, Applied Pharmaceutical Innovation (API) and the City of Edmonton have finalized lease negotiations for the vacant land in…
MEDIA RELEASE: Edmonton Global and Applied Pharmaceutical Innovation join forces to accelerate growth in life sciences sector
August 23, 2023 (Edmonton, Alberta) – On June 22nd, Edmonton Global announced that they have established a Memorandum of Understanding (MOU) with the not-for-profit organization…
The complex world of clinical trials
To mark International Clinical Trials Day on May 20, API is highlighting the interesting work that goes into clinical trials Clinical trials are an important…
Partnerships made the Canadian Critical Drug Initiative happen
How the CCDI came to be The Canadian Critical Drug Initiative (CCDI) started with a vision by life sciences leaders and economic developers in Alberta…
Read Moreabout Partnerships made the Canadian Critical Drug Initiative happen
Partnership strengthens clinical trial support
Applied Pharmaceutical Innovation and IMPACT program at Innovate Calgary partner to provide companies with greater clinical trial expertise Applied Pharmaceutical Innovation (API) and the Integrated…
Read Moreabout Partnership strengthens clinical trial support
API to offer a big boost to Canadian drug development
Innovators and researchers will have a new path to developing new drugs with the Canadian Critical Drug Initiative. As we add new production and manufacturing…
Read Moreabout API to offer a big boost to Canadian drug development
$80.5M federal funding puts API at the heart of national drug strategy
Government of Canada funds the Canadian Critical Drug Initiative, growing capacity for drug research, development and manufacturing The Government of Canada has invested $80.5 million…
Read Moreabout $80.5M federal funding puts API at the heart of national drug strategy
March 2023 Newsletter
API Stories API’s industry support grows as new manager of the Biotechnology Business Development Centre Andrew MacIsaac, API’s CEO, says, “we’ve been working round the…